FARRA, ROSSELLA
 Distribuzione geografica
Continente #
NA - Nord America 8.185
EU - Europa 5.867
AS - Asia 1.381
AF - Africa 39
SA - Sud America 26
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 11
Totale 15.529
Nazione #
US - Stati Uniti d'America 8.127
PL - Polonia 1.684
IT - Italia 1.067
SE - Svezia 850
DE - Germania 696
CN - Cina 550
UA - Ucraina 441
HK - Hong Kong 289
TR - Turchia 211
GB - Regno Unito 184
RU - Federazione Russa 184
FI - Finlandia 170
SG - Singapore 168
FR - Francia 141
IE - Irlanda 116
BG - Bulgaria 114
BE - Belgio 60
CA - Canada 54
NL - Olanda 33
CH - Svizzera 31
IN - India 29
SN - Senegal 26
VN - Vietnam 26
KR - Corea 24
IR - Iran 23
AU - Australia 19
ES - Italia 17
JP - Giappone 17
BR - Brasile 15
CZ - Repubblica Ceca 12
LU - Lussemburgo 11
EU - Europa 10
TW - Taiwan 10
GR - Grecia 9
MY - Malesia 8
PK - Pakistan 8
DK - Danimarca 7
EG - Egitto 7
HR - Croazia 7
RS - Serbia 7
TH - Thailandia 7
CL - Cile 6
IL - Israele 6
NO - Norvegia 5
AT - Austria 4
PT - Portogallo 4
AR - Argentina 3
MU - Mauritius 3
RO - Romania 3
AL - Albania 2
CO - Colombia 2
EE - Estonia 2
HU - Ungheria 2
MD - Moldavia 2
MX - Messico 2
PA - Panama 2
SI - Slovenia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BF - Burkina Faso 1
IQ - Iraq 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SA - Arabia Saudita 1
Totale 15.529
Città #
Warsaw 1.679
Woodbridge 1.039
Ann Arbor 923
Fairfield 914
Chandler 828
Houston 616
Ashburn 587
Jacksonville 432
Wilmington 423
Trieste 416
Seattle 342
Cambridge 291
Hong Kong 273
Princeton 211
Izmir 182
Beijing 168
Dearborn 164
Sofia 113
Dublin 112
Boardman 84
Singapore 82
San Diego 53
Brussels 48
Los Angeles 48
Bremen 38
Helsinki 34
Milan 32
Redmond 32
Mestre 31
Ottawa 30
Kunming 28
Washington 28
Düsseldorf 27
Redwood City 27
Dakar 26
Falls Church 26
Hefei 25
Bern 24
Chicago 24
Nanjing 23
Jinan 21
Phoenix 21
Seoul 21
Venezia 21
Duino-Aurisina 20
Des Moines 19
Dong Ket 18
Kocaeli 18
Shanghai 18
Grafing 17
Napoli 17
Columbus 15
Hebei 15
Fagagna 14
Padova 14
Nanchang 13
Sacile 13
Atlanta 12
Norwalk 12
Salerno 12
Tianjin 12
Fuzhou 11
Guangzhou 11
Shenyang 11
Udine 11
Fremont 10
Ghent 10
Taipei 10
Buffalo 9
Múggia 9
Sydney 9
Bologna 8
Chengdu 8
Toronto 8
Vancouver 8
Zhengzhou 8
Brno 7
Dongguan 7
Hangzhou 7
Indiana 7
Naples 7
Rome 7
San Francisco 7
Verona 7
Montreal 6
Nanning 6
New York 6
Pune 6
Cairo 5
Central 5
Dudenhofen 5
Granada 5
London 5
Madrid 5
Martignacco 5
Tokyo 5
Torre Del Greco 5
Xian 5
Zagreb 5
Aachen 4
Totale 11.106
Nome #
Polysaccharides for the delivery of antitumor drugs 380
Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease 373
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 369
Pharmacokinetics and immunomodulatory effect of lipophilic Echinacea extract formulated in softgel capsules 365
Potential applications of nanocellulose-containing materials in the biomedical field 357
A nanoporous surface is essential for glomerular podocyte differentiation in three-dimensional culture. 335
GT75 aptamer against eukaryotic elongation factor 1A as potential anticancer drug for castrate-resistant prostate cancer (CRPC). 322
Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma 307
Use of low field NMR for the characterization of gels and biological tissues 301
Therapeutic potential of Nucleic acid-based drugs in coronary hyper-proliferative vascular diseases 219
Serum Response Factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 209
Strategies for delivery of siRNAs to ovarian cancer cells 209
Effect of cystic fibrosis sputum rheology on lungs drug delivery by inhalation 209
Mathematical modeling of drug release from natural polysaccharides based matrices 208
Recent advances in smart biotechnology: Hydrogels and nanocarriers for tailored bioactive molecules depot 207
The role of the transcription factor E2F1 in hepatocellular carcinoma 206
null 203
Therapeutic potential and delivery strategies for nucleic acid-based drugs 198
null 184
Current strategies to improve the efficacy and the delivery of nucleic acid based drugs 183
Guar gum/borax hydrogel: rheological, low field NMR and release characterizations 183
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells 182
Characterization of PLLA scaffolds for biomedical applications 179
Exploring the Shape Influence on Melting Temperature, Enthalpy, and Solubility of Organic Drug Nanocrystals by a Thermodynamic Model 178
Use of Low field NMR for the characterisation of gels and biological tissues 178
Drug delivery from polymeric matrices 176
Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs 173
Ottimizzazione di hydrogel alginato-pluronico per il rilascio di farmaci basati sul DNA 170
Translation Elongation 169
Thermo-responsive hydrogels from cellulose-based polyelectrolytes and catanionic vesicles for biomedical application 165
null 162
Physical characterization of alginate–Pluronic F127 gel for endoluminal NABDs delivery 162
Membranes in Drug Delivery 162
2D DYNAMICAL SIMULATION OF A VIBRATIONAL MILL 160
Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels. 156
Modulating carbohydrate-based hydrogels as viscoelastic lubricant substitute for articular cartilages 156
Designing of polymeric gels mimicking the normal and fibrotic liver tissues: Effect of viscoelasticity on cells adhesion and survival 155
The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade 153
Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells 153
Alcohol reduces MMP-2 in humans and isolated smooth muscle cells. 151
null 150
Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs 148
null 148
Dissecting the expression of EEF1A1/A2 genes in human prostate cancer cells: the potential od EEF1A2 as a hallmark for prostate transformation and progression 147
Characterization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 146
Comparison between recombinant baculo and adenoviral-vectors as transfer system in cardiovascular cells 143
Rheological and mechanical properties of pluronic-alginate gels for drug-eluting stent coating 143
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects 143
Effects of E2F1-cyclinE1-E2 circuit down-regulation in hepatocellular carcinoma cells 138
Improving siRNA Bio-Distribution and Minimizing Side Effects 136
Synthesis and Spontaneous Polymerization of Oligo(ethyleneglycol)-Conjugated Benzofulvene Macromonomers.A Polymer Brush Forming a Physical Hydrogel 134
Aptamers as nano-targeting delivery devices or anti-cancer drugs for fighting tumours 128
Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells 127
Potential applications of small interferring RNA in the cardiovascular field 126
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials 124
Proliferation of human primary vascular smooth muscle cells depends on serum response factor. 123
null 121
Characterisation of nucleid acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 120
null 119
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 118
E2F1 as a molecular drug target in ovarian cancer 116
Synthesis and characterization of polyaspartamide copolymers obtained by ATRP for nucleic acid delivery 115
Propaedeutic study for the delivery of nucleic acid-based molecules from PLGA microparticles and stearic acid nanoparticles 111
null 111
Swelling of viscoelastic matrices by viscoelastic fluids 110
Can rheology be useful in the cystic fibrosis frame 109
Uso di small interfering RNA (SIRNA) per il trattamento di patologie caratterizzate da iperproliferazione cellulare 108
SiRNAs targeted against cyclin E1, cyclin E2 and E2F1 down regulate the growth of Hepatocellular Carcinoma showing their potential use in the prevention of this type of tumor 108
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 108
Development of a simple, biocompatible and cost-effective Inulin-Diethylenetriamine based siRNA delivery system 108
Evaluation of the contribution of the elongational factor 1 A isoforms in hepatocellular carcinoma celss growth 108
Hydrogels mesh size evaluation 106
Rheological properties of aqueous Pluronic-alginate systems containing liposomes 106
“The expression levels of the translational factors eEF1A1/2 correlate with the cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade” 105
"Charactherization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices" 104
Characterization of liposomes for the delivery of SiRNAs in the treatment of coronary restenosis 104
Cyclin E1, E2 and E2F1 targeted siRNAs down regulate the growth of coronary smooth muscle cell, thus showing their potential use in the prevention of in-stent restenosis 104
null 103
PDPG Polymer as a targeted delivery system for siRNAs to hepatocellular carcinoma cells 103
SIMPLE, BIOCOMPATIBLE AND COST-EFFECTIVE INULIN BASED siRNA DELIVERY SYSTEMS 101
The targeting of the elongation factor 1A by a DNA aptamer impairs the viability of hepatocarcinoma cells 101
Role of E2F1-cycline1-cycline2 circuit in hepatocellular carcinoma cell proliferation and therapeutic potential of its down-regulation by siRNAs 99
Charactherization of liposomes for the delivery of siRNAs in the treatment of coronary restenosis 97
Effects of various promoter derived sequences on the cleavage kinetic of an hammerhead ribozyme directed against cyclin E1 mRNA. 91
Potential Application Of Proteasome Inhibitor Bortezomib For Treatment Of Hepatocellular Carcinoma 90
Drug delivery and mathematical modeling: an historical perspective 89
Evaluation of bortezomib impact on cell-cycle related genes in the hepatocellular carcinoma cell lines hepg2 and jhh6 by means of microarray analysis 88
Potential Application Of Proteasome Inhibitor Bortezomib For the Treatment Of Hepatocellular Carcinoma 85
Pluronic gel matrices for stent coating 82
Characterisation of liposomes for the delivery of siRNAs in the treatment of coronary restenosis 82
Use of Rheology and portable Low-Field NMR for the monitoring of lung functions in cystic fibrosis patients 80
Mesh Size Distribution Determination of Interpenetrating Polymer Networks Hydrogels 79
Use of low field nuclear magnetic resonance to monitor lung inflammation and the amount of pathological components in the sputum of cystic fibrosis patients 79
Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach 76
Combined use of rheology and portable low-field NMR in cystic fibrosis patients 75
null 74
ANALYSIS AND MODELLING OF THE DISSOLUTION OF POLYDISPERSED SPHERICAL DRUG PARTICLES 73
USO SINERGICO DELLA REOLOGIA E DELLA RISONANZA MAGNETICA NUCLEARE A BASSO CAMPO PER CARATTERIZZARE L’ESPETTORATO DI PAZIENTI CON FIBROSI CISTICA 71
Hydrogel mesh size evaluation 70
Role of E2F1–Cyclin E1-Cyclin E2 Circuit in Human Coronary Smooth Muscle Cell Proliferation and Therapeutic Potential of Its Downregulation by siRNAs 69
Totale 15.147
Categoria #
all - tutte 36.974
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.974


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.215 180 161 166 460 249 427 423 337 283 190 230 109
2020/20211.886 194 128 152 262 159 160 137 151 97 214 69 163
2021/20221.562 40 87 58 207 38 140 111 62 137 129 183 370
2022/20232.489 232 379 247 362 222 358 39 197 258 46 108 41
2023/20241.421 78 84 89 81 166 165 194 262 26 86 106 84
2024/202517 17 0 0 0 0 0 0 0 0 0 0 0
Totale 15.981